Timing of angiotensin system inhibitor use and overall survival in patients on tyrosine kinase inhibitors for renal cell carcinoma.
2014 ◽
Vol 32
(15_suppl)
◽
pp. e15587-e15587
◽
2018 ◽
Vol 16
(4)
◽
pp. 266-273
◽
2010 ◽
Vol 107
(2)
◽
pp. 214-219
◽
2015 ◽
Vol 13
(4)
◽
pp. 280-286
◽
Keyword(s):